Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Nitric-oxide releasing chitosan nanoparticles towards effective treatment of cutaneous leishmaniasis

Full text
Author(s):
Cabral, Fernanda V. [1] ; Pelegrino, Milena T. [2, 3] ; Seabra, Amedea B. [2, 3] ; Ribeiro, Martha S. [1]
Total Authors: 4
Affiliation:
[1] Energy & Nucl Res Inst IPEN CNEN SP, Ctr Lasers & Applicat, Av Prof Lineu Prestes 2242, BR-05508000 Sao Paulo, SP - Brazil
[2] Univ Fed ABC, Ctr Nat & Human Sci, Av Estados 5001, BR-09210580 Santo Andre, SP - Brazil
[3] Univ Fed ABC, Nanomed Res Unit NANOMED, Av Estados 5001, BR-09210580 Santo Andre, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: NITRIC OXIDE-BIOLOGY AND CHEMISTRY; v. 113, p. 31-38, SEP 1 2021.
Web of Science Citations: 0
Abstract

Cutaneous leishmaniasis (CL) is a major public health problem caused by Leishmania parasites that produce destructive and disfiguring skin conditions. There is an urgent need for alternative topical therapies due to the limitations of current systemic treatments. Recently, we have synthesized nitric oxide-releasing chitosan nanoparticles (NONPs) and shown their potential in vitro against Leishmania amazonensis. Herein we evaluated the application of NONPs for the treatment of CL on infected BALB/c mice. Mice were treated with topical administration of increasing concentrations of NONPs and disease progression was investigated regarding parasite load, lesion thickness, and pain score. As a result, we observed a dose-dependent NONPs effect. Parasite burden and lesion thickness were substantially lower on animals receiving NONPs at a 2 mM concentration compared to untreated control. Moreover, the clinical presentation of the lesions did not show any visible signs of ulcer, suggesting clinical healing in these animals. This successful outcome was sustained for at least 21 days after therapy even in one single dose. Thus, we demonstrate that NONPs are suitable for topical administration, and represent an attractive approach to treat CL. (AU)

FAPESP's process: 18/08194-2 - Essential oil amended with metal nanoparticles functionalized with nitric oxide as a strategy to control plant pathogens in the agriculture
Grantee:Amedea Barozzi Seabra
Support Opportunities: Regular Research Grants